#JanIssue - Twitter Hashtag

over 2 years ago

إنّ اعتماد المرأة على ذاتها يتجلى كمسيرة شجاعة وتحدي، حيث تنقلب الصعاب إلى فرص والأحلام إلى حق، إخترنا لكم أبرز النساء القامعات والمبدعات، يخترقن الصعاب ويصنعن تحولًا حقيقيًا. فما هو التحول الي تطمحين له؟ #HiaMag #ByHiaMag #JanIssue #TheGameChangers #مجلة_هي #عدد_يناير

0

329

مجلة هي

@hiamag

over 2 years ago

في كواليس اللحظات الساحرة، حيث تتشابك التفاصيل وتنسج القصص. تتألق النجمة أضواء بدر في لحضات الخفاء، التي تسبق اللقاء بالعالم الخارجي من الضحكات العفوية إلى لمسات الأناقة، خلف الستار في جلسة التصوير للغلاف مع لمسة من المرح والأناقة! #HiaMag #JanIssue #TheGameChangers #مجلة_هي

0

3

0

978

مجلة هي

@hiamag

over 2 years ago

تغيير الستايل بأسلوب ممتع ومبهج من رائعة إلى أروع، فلماذا نكتفي بمستوى واحد من الأناقة؟ أي ستايل تختارين لنفسك؟ #HiaMag #ByHiaMag #JanIssue #TheGameChangers #مجلة_هي

0

315

مجلة هي

@hiamag

over 2 years ago

في جلسة التصوير الخاصة مع نجمة غلاف #عدد_يناير ، طرحنا على #أضواء_بدر هذه الأسئلة السريعة. ما هي أعمالها الجديدة؟ #HiaMag #ByHiaMag #JanIssue #TheGameChangers #مجلة_هي

0

1

1K

조 ◡̈ (ia) @kshseonhohada

over 5 years ago

Staff.diary IG update [210115] “Just seeing the photo from the pictorial shoot... Heard that many persons’ hearts are tied up...?🤦‍♀️🤦🏻🤦‍♀️” Thank u Kimsda for working hard today again..really appreciate it😊 #KimSeonHo #김선호 #cosmopolitan #2021 #Janissue #김스다 #수고했어요

kshseonhohada's tweet photo. Staff.diary IG update [210115]
“Just seeing the photo from the pictorial shoot...
Heard that many persons’ hearts are tied up...?🤦‍♀️🤦🏻🤦‍♀️”

Thank u Kimsda for working hard today again..really appreciate it😊

#KimSeonHo #김선호 #cosmopolitan #2021 #Janissue #김스다 #수고했어요 https://t.co/qQuOf2tppD

0

5

1

0

조 ◡̈ (ia) @kshseonhohada

over 5 years ago

Staff.diary IG update [210115] “Together with Actor Seonho’s shy greeting Pls have a good (preferred) day☺️🙈👋” That..was really shy n cute🥺🙈☺️ #KimSeonHo #김선호 #cosmopolitan #2021 #Janissue

0

3

0

Design Middle East @DesignMidEast

over 5 years ago

This is our super issue to kick-start the New Year. Catch the glimpses of the Design Middle East Awards, all the celebration and winners revealed in this issue https://t.co/d5LmD9nLaB #designmeawards #janissue #jan2021

DesignMidEast's tweet photo. This is our super issue to kick-start the New Year. Catch the glimpses of the Design Middle East Awards, all the celebration and winners revealed in this issue
https://t.co/d5LmD9nLaB
#designmeawards #janissue #jan2021 https://t.co/UQ6F2K6du8

0

4

3

0

NatRevRheumatol @NatRevRheumatol

over 5 years ago

#JanIssue | Authors of the latest #OARSI and #ESCEO recommendations for the management of knee #osteoarthritis and independent experts compare and contrast these guidelines and provide insights into their differences in our #Perspectives article https://t.co/CJLudVG6G4

NatRevRheumatol's tweet photo. #JanIssue | Authors of the latest #OARSI and #ESCEO recommendations for the management of knee #osteoarthritis and independent experts compare and contrast these guidelines and provide insights into their differences in our #Perspectives article

https://t.co/CJLudVG6G4 https://t.co/N9uvqe430q

0

22

6

3

0

NatRevRheumatol @NatRevRheumatol

over 5 years ago

#JanIssue | The #COVID19 pandemic led to unprecedented changes in #rheumatology clinical practice. We asked 5 experts to describe how their clinical practice has changed and the opportunities and challenges that lie ahead. Read the Viewpoint for #free https://t.co/s2rw1cW6wb

NatRevRheumatol's tweet photo. #JanIssue | The #COVID19 pandemic led to unprecedented changes in #rheumatology clinical practice. We asked 5 experts to describe how their clinical practice has changed and the opportunities and challenges that lie ahead.

Read the Viewpoint for #free https://t.co/s2rw1cW6wb https://t.co/Yjz7esmTDb

0

13

2

0

NatRevRheumatol @NatRevRheumatol

over 5 years ago

#JanIssue | Eliminating or altering #senescent cells with senolytics or senomorphics could stop #osteoarthritis progression and pathogenesis. Read our #Review to learn more https://t.co/yrGFmu4NRK

NatRevRheumatol's tweet photo. #JanIssue | Eliminating or altering #senescent cells with senolytics or senomorphics could stop #osteoarthritis progression and pathogenesis.

Read our #Review to learn more https://t.co/yrGFmu4NRK https://t.co/TyMAuOjBta

0

16

2

4

0

NatRevRheumatol @NatRevRheumatol

over 5 years ago

#JanIssue | For young people with rheumatic diseases, the transition from paediatric to adult #rheumatology care is a vulnerable time, and delays or disruption in their care can lead to adverse outcomes. Find out more about the gaps in transitional care https://t.co/0y1gryRpyp

NatRevRheumatol's tweet photo. #JanIssue | For young people with rheumatic diseases, the transition from paediatric to adult #rheumatology care is a vulnerable time, and delays or disruption in their care can lead to adverse outcomes.

Find out more about the gaps in transitional care https://t.co/0y1gryRpyp https://t.co/LQcjxPtEzQ

0

8

1

0

NatRevRheumatol @NatRevRheumatol

over 5 years ago

#JanIssue | Nerve growth factor has been investigated as a therapeutic target for #osteoarthritis and chronic low #backpain, yet worries over adverse effects have stalled drug development. Find out more in our #Review https://t.co/mxdVNgyDRy

NatRevRheumatol's tweet photo. #JanIssue | Nerve growth factor has been investigated as a therapeutic target for #osteoarthritis and chronic low #backpain, yet worries over adverse effects have stalled drug development.

Find out more in our #Review https://t.co/mxdVNgyDRy https://t.co/2bYfoj1iL1

0

10

1

0

NatRevRheumatol @NatRevRheumatol

over 5 years ago

#JanIssue | The new 2019 EULAR–ACR classification criteria for #lupus performed well in the initial derivative and validation cohorts. But do these criteria outperform previous classification criteria across sexes, disease durations or ethnicities? https://t.co/3iDp9UjRjH

NatRevRheumatol's tweet photo. #JanIssue | The new 2019 EULAR–ACR classification criteria for #lupus performed well in the initial derivative and validation cohorts. But do these criteria outperform previous classification criteria across sexes, disease durations or ethnicities?

https://t.co/3iDp9UjRjH https://t.co/mCiLsHIYAi

0

16

2

3

0

NatRevRheumatol @NatRevRheumatol

over 5 years ago

#JanIssue | A better understanding of the mechanisms behind refractory #rheumatoidarthritis in the presence and absence of inflammation could help to improve the treatment of this condition. Read our #Review for #free https://t.co/4dIrBUpDe9 #SharedIt

$NatRevRheumatol's tweet photo. #JanIssue | A better understanding of the mechanisms behind refractory #rheumatoidarthritis in the presence and absence of inflammation could help to improve the treatment of this condition. Read our #Review for #free https://t.co/4dIrBUpDe9 #SharedIt https://t.co/8dUJiR9Djn$

1

8

4

0

NatRevRheumatol @NatRevRheumatol

over 5 years ago

#JanIssue | Machine learning approaches applied to genomic datasets offer great promise to deliver personalized medicine but their application must first be optimized. Find out more in our #NewsandViews #machinelearning #personalizedmedicine https://t.co/kTARHLRUhY

NatRevRheumatol's tweet photo. #JanIssue | Machine learning approaches applied to genomic datasets offer great promise to deliver personalized medicine but their application must first be optimized. Find out more in our #NewsandViews

#machinelearning #personalizedmedicine

https://t.co/kTARHLRUhY https://t.co/ScFW6BtruV

0

10

11

0

NatRevRheumatol @NatRevRheumatol

over 5 years ago

Our #JanIssue is online now! https://t.co/HrPHfYsp2I

0

4

0

1

0

Nicky O'Shea @nicky_oshea44

over 5 years ago

@PsychologiesMag @GillH1973 love this #JanIssue #AmWriting

1

4

1

0

VIVID Marketing @VIVIDmktng

over 6 years ago

A truly inspirational story from @MissEm_Martlets P60-63 in @DynamicWomenUK @PlatBusMag ...for anyone struggling to find motivation in this first week of January! Read here: https://t.co/rhnvaFZdqs #JanIssue #MindOverMatter #MustRead #HappyNewDecade